ARTICLE
Auteur(s) : Peter Fritsch, Walter Burgdorf
The European Journal of Dermatology and the European Dermatology
Forum have agreed to reproduce, with permission, the White
Book © 2005 ABW Wissenschaftsverlag GmbH.This work was a joint
enterprise bringing together many European dermatologists, chosen
to obtain a broad representation from across Europe and according
to their expertise. Although the content of the “White Book” was
primarily intended for non-dermatologists it is felt that it will
also prove valuable to all our colleagues.In this first part, the
EDF presents the aims of the White Book and two chapters : “The
skin and its diseases: an overview ” and “Epidemiology of
skin diseases in Europe”.Introduction
Definition of aims
The White Book paints in broad strokes a portrait of
dermatology, designed to provide other physicians, university
officials, public health administrators, politicians, media and
other opinion makers with a better understanding of the many issues
facing the specialty today. It aims to:
- 1) Explain the raison d’être for dermatology, showing
its roles in clinical practice, medical education and scientific
research.
- 2) Show the wide spectrum of diseases which are treated
by dermatologists in Europe.
- 3) Emphasize the impact of cutaneous diseases both at an
individual and a societal level, considering selected disorders in
more detail.
- 4) Present a catalogue of the accomplishments of
dermatology, point out the shortcomings and indicate areas of
future development and continuing concern.
- 5) Document the state of dermatology in the European
Community, Switzerland and the candidate states of Eastern Europe,
as well as introducing the pan-European dermatologic
organizations.
The many faces of dermatology
The skin and its diseases: an overview
Dermatology is the science of the skin and its diseases. It
includes the study of both the normal skin, i.e. its anatomy,
physiology and function, and the skin in disease, i.e. of the
causes, morphological appearance and pathophysiology of skin
disorders, the methods of diagnosing them, and the strategies of
their treatment and management.
The skin is the outer coating of the human body serving
many vital protective and sensory roles. It forms a nearly absolute
physical barrier between the organism and the environment, thus
preventing drying out of the body and penetration of foreign
substances. Other essential functions include thermoregulation,
protection against mechanical, chemical and ultraviolet insult,
host defence mechanisms against microbial invasion, initiation and
execution of immune reactions (the skin harbours the most
peripheral outpost of the immune system) and perception of touch,
heat and cold, pain, itch and other sensations. All these functions
may be altered or abolished in skin diseases.
Anatomically, the skin consists of three layers: the epidermis
(a keratinizing epithelium), the dermis (the connective tissue) and
the subcutis (subcutaneous adipose tissue). The thin epidermis is a
self-renewing tissue which, by differentiation, forms the horny
layer (the outermost barrier layer) and hosts commensal cells such
as melanocytes (pigment-producing cells) and Langerhans cells (skin
specific dendritic cells specialized in antigen presentation). The
much thicker dermis is responsible for strength and mechanical
properties to the skin due to its high content of collagen fibres;
the dermis of animal skins is used to make leather, a most stable
material. The dermis is also rich in blood and lymphatic vessels as
well as nerve fibres. The adnexal organs – hair, nails, sebaceous
and sweat glands – are special structures derived from epithelium
which perform a variety of special tasks.
The diseases of the skin are particularly common, varied,
and plentiful owing to the large size of the skin, its complex
structure and its permanent exposure to environmental influences.
The number of skin diseases has been estimated at as high as 3000,
not counting questionable or ill-defined subtypes – a number higher
than in any other organ of the body. Every individual is affected
by skin problems during their lifetime. The prevalence of skin
diseases tends to increase with age, and there is hardly any
individual over 50 years who would not benefit from dermatologic
care.
Causes and categories of skin disease. Skin diseases
result from an interplay of causative factors which fall into three
general categories: dispositional (genetic or acquired),
environmental and systemic (influences from the organism as a
whole). All three kinds of factors contribute to the
pathophysiology of every skin disease, but the relative relevance
of each of them may differ widely. The following main groups of
skin diseases may be distinguished (with representative
examples):
- – Damage from exogenous physical and chemical trauma:
e.g. heat and cold trauma, chemical burns.
- – Intolerance reactions against exogenous agents. In
these, the character of the skin disease is not so much shaped by
the causative trigger factor but by the reaction of the body
against it. There is a limited number of reaction patterns which
can be elicited by an enormous number of triggers. For example,
both hives and eczema have many causes, but conversely, many drugs
may cause both.
- – Infections. The skin provides a favourable environment
and is normally colonized by non-pathogenic bacteria. Some
pathogenic bacteria may cause severe infections requiring prompt
treatment, especially if the skin barrier is disturbed. Infections
were historically the most important diseases of the skin, and they
still are in Third World countries. Classification is usually based
on the causative organisms: bacterial (e.g. erysipelas), viral
(e.g. herpes virus infections), mycotic (e.g. dermatophytoses) and
parasitic (e.g. scabies) infections. In skin infections, the
clinical appearance is moulded by the interaction of infectious
agents with host defence mechanisms. Incidence and severity of skin
infections is much higher in the immunocompromised individual (e.g.
in the context of organ transplantation or HIV infection).
Furthermore, infectious agents play important roles in eliciting or
maintaining classical skin diseases (psoriasis, atopic dermatitis,
intolerance reactions).
- – Tumours. Because of its direct exposure to
environmental carcinogens and its complex anatomy, the skin has a
higher incidence and diversity of tumours than any other organ.
Melanoma, the malignant tumour of the pigment cells, is the most
serious tumour of the skin and one of the most aggressive human
tumours. Its incidence is 10-30/105/year in Caucasians,
depending on climatic factors. Squamous and basal cell carcinomas,
often collectively referred to as non-melanoma skin cancer, are
extremely common in the ageing white population of Europe.
UV light is the most important carcinogen. Increased UV exposure
due to changed life style patterns is thought to be the cause of
the unprecedented exponential upsurge of melanoma and non-melanoma
skin cancer which has been registered in the white population world
wide in the past decades (doubling of the incidence every 10-15
years).
Skin tumours tend to be more prevalent and aggressive in
immunocompromised individuals (organ transplantation,
haematological disease, HIV infection). There are several
hereditary syndromes which are associated with high incidences of
skin tumours, e.g. the familial atypical mole syndrome, nevoid
basal cell carcinoma syndrome, xeroderma pigmentosum and
others.
- – Skin diseases caused by “systemic”
factors: Historically, skin diseases have been principally
perceived as caused by internal disease (“skin as a mirror of the
body”). While it is clear that this extrapolation was generally
untenable, it still holds true for some skin disorders. Metabolic
diseases (e.g. diabetes, hyperlipidemias, porphyrias, amyloidosis)
are often accompanied by highly specific skin symptoms which may
alert the physician to the correct diagnosis; the same is true for
a spectrum of cardiovascular, pulmonary and digestive tract
diseases (e.g. dermatitis herpetiformis accompanying gluten
sensitive enteropathy) and cancer of internal organs which may be
associated with pathognomonic paraneoplasias of the skin. Systemic
autoimmune disorders – collagen vascular diseases, systemic
vasculitides – are regularly associated with skin symptoms. The
skin is also the target of organ specific autoimmune diseases (e.g.
alopecia areata, vitiligo) and of autoimmune bullous disorders
(pemphigus and pemphigoid groups). The psychogenic causation of
skin diseases is an old but still widely held concept whose
importance is probably overestimated.
- – Genetic skin disorders. This category is characterized
by genetic structural or functional defects of the skin. Major
groups include the disorders of keratinization – e.g. ichthyoses;
hereditary bullous disorders – epidermolysis bullosa; systemic
malformation syndromes – Recklinghausen disease; and diseases
associated with increased tumour formation – xeroderma pigmentosum,
Werner disease. The genetic basis of many pertinent disorders has
been elucidated in the past decade.
- – Inflammatory disorders of unknown aetiology. This
group of diseases has traditionally occupied a major part of
dermatology but is being slimmed down dramatically, as research
offers more and more insights into cutaneous inflammation. Still
included in this category are common important diseases such as
psoriasis and lichen planus.
- – Diseases of the skin appendages: Acne, an inflammatory
disorder involving sebaceous glands and hair follicles, is probably
the most common skin disease, affecting almost every teenager. Hair
loss (alopecia) is a distressing problem with a variety of
causes.
Venereal diseases (sexually transmitted infections, STI).
Dermatology has been historically linked to venereology because of
the plethora of skin symptoms found in STI, particularly in
syphilis. In most European countries, dermatology and venereology
are practiced and taught as a single discipline whereas they have
been separated in the English-speaking countries. The most common
venereal diseases are genital warts caused by human papilloma virus
(HPV), and genital herpes infections, both prevalent among
adolescents. The classical venereal diseases, syphilis and
gonorrhoea, are still relevant: syphilis especially in Eastern
European countries and gonorrhoea as imported from the Far-East and
because of emerging drug-resistance. Venereal chlamydia infection
is continuously increasing, especially among adolescents and young
adults, despite modern diagnostics and simple therapy. The AIDS
pandemic has greatly increased concern over sexually transmitted
infections; dermatological institutions are prominently involved in
the management of the HIV infection, particularly in the
German-speaking countries.
Spectrum of dermatological care in Europe. Despite its
common historical basis and interwoven development, dermatology as
a specialty is differently defined in the European countries. Core
dermatology consists of medical dermatology, venereology (except
Great Britain) and dermatosurgery as well as dermatopathology. Some
fields are covered by other specialties along with dermatology:
allergology and/or clinical immunology is shared with
paediatricians, otolaryngologists and rheumatologists; phlebology
with vascular surgeons, and proctology with general surgeons.
Dermatology in German-speaking countries is particularly
encompassing and also includes andrology along with all the other
subspecialties mentioned above. As Europe-wide standards are
instituted for medical education and practice, dermatology faces a
special challenge in preserving its many facets.
Relevance of skin diseases. Skin diseases are a major
source of morbidity. For the population as a whole, morbidity
results less from life threatening acute skin disease or malignant
skin tumours but rather from chronic dermatologic illness.
Occupational dermatoses (eczema) range among the most frequent
causes of occupational disability, need for job retraining, and
even invalid status with accompanying social costs.
Relatively few skin diseases are directly and acutely life
threatening. Included in this small group are acute severe
intolerance reactions such as anaphylaxis and angiooedema, bee and
wasp venom allergy, and drug rashes like the carbamazepine
hypersensitivity syndrome or toxic epidermal necrolysis. Some of
the most aggressive tumours of man arise in the skin: melanoma,
some types of skin lymphomas, Merkel cell tumours and others.
Chronic severe skin disease is much more prevalent and accounts for
the most part of the patient’s suffering and incapacitation:
psoriasis, atopic dermatitis, recalcitrant bullous diseases,
chronic wounds such as venous and decubitus ulcers, smouldering
skin lymphomas (usually mycosis fungoides), scleroderma, and
genodermatoses including severe ichthyoses and hereditary bullous
diseases.
Some skin diseases may not seem to qualify as severe diseases at
first glance, but their psychological impact, particularly on the
developing personality, may be detrimental. Acne vulgaris,
disfiguring birth marks or cutaneous anomalies have a high impact
on wellness and the social abilities of adolescents, as does
balding (androgenetic alopecia) for both sexes in adulthood. The
psychological consequences of atopic dermatitis which vexes its
bearers not only by incessant itch but also by its appearance are
proverbial (“atopic psyche”).
Moreover, dermatology has to satisfy the patients with those
abundant common and relatively mild ailments which fill the waiting
rooms and may not be so easy to diagnose and treat despite their
often seemingly trivial background: viral warts, eczemas of various
kinds, simple bacterial, viral and fungal skin infections, insect
bites, dandruff (seborrheic eczema of the scalp), dry skin, the
many stigmata of ageing skin, venous insufficiency of the lower
limbs and others. Among all these, the skin specialist has always
to keep in mind that skin symptoms may be a warning signal of
life-threatening internal disease.
Dermatology is both an inpatient and outpatient
specialty. Historically, dermatology was one of the “large”
medical specialties with similarly large wards as internal
medicine, surgery, and gynaecology and obstetrics. With the advent
of efficient antimicrobial and anti-inflammatory therapy, many skin
infections and intolerance reactions became treatable on an
outpatient basis. Due to economic constraints, dermatology wards
were reduced – sometimes dramatically – in most European countries,
while skin hospital outpatient departments were not accordingly
enlarged. The increased number of dermatologists in practice was in
many instances not sufficient to account for the lost hospital
capacity. National dermatological societies and other professional
groups all over Europe have taken a strong stance against further
reduction of hospital beds: inpatient care of severe and difficult
dermatoses, particularly of skin tumours, is necessary to maintain
full competence in diagnosis and treatment for the dermatologist
and to maximize effective teaching of medical students and
residents. It is foreseen that in the future the patients treated
in dermatological wards are more severely ill, suffer from multiple
diseases, need more internal drugs and more nursing care than
patients from the previous decades.
Who is taking care of skin diseases? A wide range of
studies in different countries have demonstrated that
dermatologists can diagnose and treat skin diseases more
efficiently than a non-dermatologist. Nonetheless, the high
incidence and prevalence of the cutaneous disease makes it
unfeasible and unreasonable that all such disorders be managed by
dermatologists. A large segment of dermatological cases are treated
by general practitioners, paediatricians and other specialists, and
dermatologists are called in only when their help is needed. This
situation is more common in rural areas than in larger cities,
where dermatologists are more easily accessible. Dermatological
training programs have a long tradition of educating
non-dermatologists in the management of common skin diseases.
It has proven an unachievable task to define the borderline
between skin diseases which are “common” to all specialties and
those which are reserved for the skin specialist, a line which is
also dependent on historical, cultural and personal variables. In
any event, skin diseases are among the most frequent diseases seen
by the general practitioner, and the costs of dermatological
treatment (particularly topical agents) is a significant part of
most health care budgets. The situation varies in the European
countries. In the German-speaking countries, the number of
dermatologists is high, and they see a rich spectrum of skin and
related diseases. In the United Kingdom, the number of
dermatologists and dermatological institutions is low, most skin
diseases are managed by general practitioners, and a major role of
the skin specialist is to act as a consultant for rare and
difficult skin patients.
Skin as a tool for basic medical research. The skin has
long been a favoured site for research into a variety of basic
biologic processes, because it is accessible and can be easily
observed, manipulated and otherwise studied. Many important
biological principles were first discovered in the skin. To cite
but one example, the study of Langerhans cells by dermatologists
opened the way for many exciting advances in dendritic cell
biology, providing not only a better understanding of how the body
interacts with foreign antigens but even introducing potential
therapeutic tools such as cancer vaccines. Dermatology has always
been a scientifically oriented specialty, addressing critical
problems with the latest scientific methods. In the past fifty
years, research tools have advanced from histopathology,
immunofluorescence, immuno- and enzyme histochemistry, and electron
microcopy to include all of the modern methods of molecular biology
and genetics. Experimental dermatology has experienced a “Golden
Age” in the past few decades, placing dermatology in the leading
group of research-oriented specialties. The main dermatologic
research journal, the “Journal of Investigative Dermatology” is a
highly regarded journal with a high impact factor.
In addition, many skin diseases are employed as models to
investigate modern therapeutic principles, since the disease course
can be so easily monitored on the skin. For example, psoriasis and
atopic dermatitis are prototypes for the evaluation of modern
methods of immune intervention with “biologicals” (agents such as
tumor necrosis factor antagonists, antibodies against specific cell
types, or cytokines). The progress in the treatment of skin
diseases in the past years is impressive; the old saying that “skin
diseases can be treated but not cured” was never correct, but today
it is becoming even less true, thanks to disease-oriented
dermatological research.
Skin disease versus cosmetics. In the last decade, there
has been a dramatic trend in dermatology towards what were
previously viewed as cosmetic problems. This emphasis has already
changed patterns of practice in the USA and threatens to do so in
Europe. The skin is responsible for many of the aesthetic
attributes of an individual, and one goal of dermatologists has
always been to improve the appearance of the skin much to the
satisfaction of patients. Traditionally dermatologists have worked
with pharmaceutical firms to develop and use skin care products,
such as moisturizers or cleansing agents.
In recent years dermatologists have turned towards what their
professional forefathers considered “strictly cosmetic problems”.
The reasons for this recent shift in emphasis are multiple. Better
treatment methods are available for many common skin diseases,
freeing up the dermatologist somewhat. In addition, adequate
reimbursement for routine non-invasive care, such as for acne,
eczema or warts is no longer available in many insurance schemes.
Thus dermatologists have started to look for other methods of
practice expansion. This trend has fit together perfectly with the
increased standard-of-living in western lands, coupled with an
emphasis on life style and wellness. Cosmetic surgical procedures
such as the removal of harmless skin lesions, epilation, laser
treatment of small vascular or pigmented lesions, liposuction,
tissue enhancement, skin resurfacing with chemical or laser
peeling, and many more are all part of the daily life of many
dermatologic practices. For academic dermatology, this swing is
viewed as a mixed blessing. First, the residents must now devote a
considerable portion of the training time to cosmetic dermatology
in order to function in the new market place. Thus, they and
consequently their departments have less time and energy to devote
to basic and clinical research. In the same tone, it is
disappointing that European dermatology with a few spectacular
exceptions has devoted relatively little of its intellectual and
physical resources to the HIV/AIDS pandemic. A final consideration
is that if dermatology becomes too strongly identified as a “luxury
specialty” concerned with cosmetic problems, it may draw a short
straw in the inevitable battles over distribution of resources for
patient care and research.
Impact of skin diseases on the health care system. Skin
diseases account for a considerable degree of morbidity in Europe.
Their significance is based to some extent on their frequency and
their considerable impairment in the “quality of life”, as best
documented for psoriasis and atopic dermatitis. As a result, about
20% of the budget for medications in some western European lands is
devoted to dermatologic preparations.
The popular image of dermatology, both among colleagues and the
general public, points in a different direction. Dermatology is
often considered a discipline with an amazingly complex,
difficult-to-understand language, dealing with rather mundane
problems which can be easily managed by any half-way qualified
physician or even in recent years, physicians’ assistant or nurse.
In addition, even in countries where dermatology is
well-established as a respected scientific discipline, it rarely
accounts for more than 1-2% of an overall clinic or health budget,
and thus has a limited lobby.
Thus, dermatology is an easy, if not always fair, target for
financial management. Dermatologic preparations are easier to
eliminate from a formulary than heart medicines, especially if they
are products designed for long-term maintenance care to help avoid
flares and subsequent hospitalizations. Dermatologic beds are
easier to eliminate than those devoted to internal medicine,
surgery, pediatrics or obstetrics. In addition, the trend toward
reimbursement for a given disease episode (DRG or diagnosis-related
group), emphasizes direct intervention with short hospital stays
and penalizes a discipline where many problems have traditionally
been handled with longer in-patient stays, such as atopic
dermatitis, psoriasis or leg ulcers. It does not take a wise man to
see that in many European countries, dermatology faces immense
financial challenges.
|